Etrolizumab

(Synonyms: rhuMAb Beta7; RG7413; PRO145223)
2 Cited Publications
Revisión del cliente

Based on 2 publication(s) in Google Scholar

Etrolizumab (rhuMAb Beta7) is a gut-selective, anti-β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with Ki values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD).

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.56%
  • No. CAS: 1044758-60-2
  • Peso molecular:144.3 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas Integrin

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00